National Healthcare Properties, Inc. NHP
Not traded — nothing to buy
Read automatically from the filing
The filing says these shares are not traded on any market. The odd-lot term may be real, but there is no way to buy the shares, so there is no trade here.
| Status | Closed |
|---|---|
| Closing date | 2026-06-16 |
| How it is priced | Fixed price |
| Odd-lot threshold | Fewer than 100 shares |
| Must tender everything you hold | Yes |
| Must tick the odd-lot box on the form | Yes |
| Price offered | USD $22.50 per share |
| Most an odd-lot tender could be | $2,227.50 |
Where each of these comes from
Every line above was read out of the filing. Here is the wording it was read from, so you can check it.
election_required = True...chase before any validly tendered Series B Shares in the Series B Offer are accepted. Within each Offer, we will first purchase Series A Shares or Series B Shares from holders of fewer than 100 of such Shares who validly tender all of their respective Shares, complete the section entitled “Odd Lots” in the Letter of Transmittal and, if applicable, the Notice of Guaranteed Delivery, and do not properly withdraw their respective Shares prior to the Expiration Date. If the aggregate purchase price for Shares that are validly tendered and not properly withdrawn as of the Expiration Date exceeds the Maximum Aggregate Purchase Amount, we will accept for purchase that...
expiry = 2026-06-16...ERRED STOCK AND 7.125% SERIES B CUMULATIVE REDEEMABLE PERPETUAL PREFERRED STOCK FOR A MAXIMUM AGGREGATE PURCHASE PRICE IN CASH OF UP TO $100 MILLION THE OFFERS, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON JUNE 16, 2026, OR ANY OTHER DATE AND TIME TO WHICH THE COMPANY EXTENDS THE OFFERS (SUCH DATE AND TIME WITH RESPECT TO EITHER OFFER, AS IT MAY BE EXTENDED, THE “EXPIRATION DATE”), UNLESS EARLIER TERMINATED. National Healthcare Properties, Inc., a Marylan...
listed = True...S THE OFFERS ARE NOT CONDITIONED ON THE RECEIPT OF FINANCING OR ANY MINIMUM NUMBER OF SHARES BEING TENDERED. THE OFFERS ARE, HOWEVER, SUBJECT TO CERTAIN OTHER CONDITIONS. SEE SECTION 6 UNDER “THE OFFERS.” The Series A Shares and Series B Shares are listed and traded on The Nasdaq Global Market (“Nasdaq”) under the symbols “NHPAP” and “NHPBP,” respectively. On May 15, 2026, the last full trading day prior to the commencement of the Offers, the last reported sale price of the Series A Shares was $21.65 per Series A Share and the last reported sale price of the Series B Shares was $20.70 per Series B Share. Stockholders are urged to obtai...
mechanism = FIXED...parate offers to purchase up to a maximum aggregate purchase price in cash of $100 million (the “Maximum Aggregate Purchase Amount”) of (i) our 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share (the “Series A Shares”), for a purchase price of $22.50 per share (the “Series A Share Price”) in cash (the “Series A Offer”), and (ii) our 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share (the “Series B Shares,” and together with the Series A Shares, the “Shares”), for a purchase price of $22.50 per share (the “Series B Share Price”, and together with the Seri...
must_tender_all = True...and not properly withdrawn will be accepted for purchase before any validly tendered Series B Shares in the Series B Offer are accepted. Within each Offer, we will first purchase Series A Shares or Series B Shares from holders of fewer than 100 of such Shares who validly tender all of their respective Shares, complete the section entitled “Odd Lots” in the Letter of Transmittal and, if applicable, the Notice of Guaranteed Delivery, and do not properly withdraw their respective Shares prior to the Expiration Date. If the aggregate purchase price for Shares that are validly tendered and not properly withdrawn as of the Expiration Date exceeds...
price = USD 22.5...00 million (the “Maximum Aggregate Purchase Amount”) of (i) our 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share (the “Series A Shares”), for a purchase price of $22.50 per share (the “Series A Share Price”) in cash (the “Series A Offer”), and (ii) our 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share (the “Series B Shares,” and together with the Series A...
priority = True...of the Expiration Date exceeds the Maximum Aggregate Purchase Amount, we will accept for purchase the maximum number of Shares validly tendered and not withdrawn having an aggregate price which does not exceed the Maximum Aggregate Purchase Amount, accepting first Series A Shares properly tendered and not properly withdrawn, then accepting Series B Shares from holders of “odd lots” (holders of fewer than 100 Series B Shares), finally accepting the Series B Shares not tendered in “odd lots”, properly tendered and not properly withdrawn, up to a number of Series B Shares having an aggregate purchase price equal to the remainder of the Maximum Aggregate Purchase Amount. Accordingly, all Series A Shares properly tendered will be accepted for pur...
threshold = 100...res in the Offers, subject to applicable law. If we do so, the preceding provisions will apply to the greater value. Odd Lots. The term “odd lots” means, in either Series A Offer or Series B Offer, all Series A Shares or Series B Shares tendered by any person who owned beneficially or of record a total of fewer than 100 such Shares and so certified in the appropriate place on the Letter of Transmittal and, if applicable, the Notice of Guaranteed Delivery. To qualify for the “odd lot” preference, an “odd lot” holder must tender all Series A Shares or Series B Shares owned by such holder in accordance with the procedures described in Section 3 below. Within each Offe...
txn_type = TENDER_OFFER...bject to the conditions (including the purchase priority assigned to Series A Shares, any “odd lot” (holders of fewer than 100 Series A Shares or Series B Shares) priority, proration of the Series B Shares and other conditions of the Offers) described in this Offer to Purchase (as it may be amended or supplemented from time to time, this “Offer to Purchase”) and in the related Letter of Transmittal and the other materials filed as exhibits to the Issuer Tender Offer on Schedule TO (the Series A Offer and Series B Offer together, as they may be amended or supplemented, the “Offers” and each, an “Offer”). We wil...
The filings
| Filed | Form | Role | On EDGAR |
|---|---|---|---|
| 2026-05-18 | SC TO-I | original (governing) | View |